These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6345294)
1. Interferon in acute myelogenous leukaemia: a preliminary report. Rohatiner AZ; Balkwill F; Lister TA Haematol Blood Transfus; 1983; 28():56-8. PubMed ID: 6345294 [No Abstract] [Full Text] [Related]
2. Experience with human lymphoblastoid interferon in acute myelogenous leukaemia (AML). Rohatiner AZ; Balkwill FR; Malpas JS; Lister TA Cancer Chemother Pharmacol; 1983; 11(1):56-8. PubMed ID: 6576869 [TBL] [Abstract][Full Text] [Related]
3. Treatment of recurrent acute myelogenous leukaemia at a single centre over a 10-year period. Davis CL; Rohatiner AZ; Amess J; Lim J; Lister TA Haematol Blood Transfus; 1990; 33():339-41. PubMed ID: 2323639 [No Abstract] [Full Text] [Related]
4. Clinical trials of human leukocyte interferon in malignancy. Hill NO; Pardue A; Khan A; Aleman C; Hilario R; Hill JM Tex Rep Biol Med; 1981-1982; 41():634-40. PubMed ID: 6763370 [No Abstract] [Full Text] [Related]
5. Complete remission in a patient with acute myelogenous leukemia treated with leukocyte alpha-interferon and cimetidine. Ankerst J; Fäldt R; Nilsson PG; Flodgren P; Sjögren HO Cancer Immunol Immunother; 1984; 17(1):69-71. PubMed ID: 6587932 [TBL] [Abstract][Full Text] [Related]
7. [Current approach to the management of patients with hemato-oncologic diseases]. Goudsmit R; van der Lelie J; Thomas LL Ned Tijdschr Geneeskd; 1987 Nov; 131(46):2057-9. PubMed ID: 3479701 [No Abstract] [Full Text] [Related]
8. Anti-interferon antibodies in alpha interferon treated patients with chronic myeloid leukaemia. Aitchison R; Allen P; Schey S; Newland AC Br J Haematol; 1991 Jul; 78(3):465-7. PubMed ID: 1873235 [No Abstract] [Full Text] [Related]
9. Treatment of Ph'-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (Intron A). Alimena G; Morra E; Lazzarino M; Liberati AM; Montefusco E; Inveradi D; Bernasconi P; Mancini M; Grignani F; Bernasconi C Cancer Treat Rev; 1988 Jan; 15 Suppl A():21-6. PubMed ID: 3277708 [No Abstract] [Full Text] [Related]
17. Interferon alfa-2c in chronic myelogenous leukemia (CML): hematologic, cytogenetic and molecular-genetic response of patients with chronic phase CML previously resistant to therapy with interferon gamma. Herrmann F; Jonas D; Helfrich SG; Lindemann A; Schleiermacher E; Mertelsmann R Blut; 1990 Oct; 61(4):226-31. PubMed ID: 2121299 [TBL] [Abstract][Full Text] [Related]
18. Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia. Kloke O; Becher R; Niederle N Blut; 1987 Nov; 55(5):453-8. PubMed ID: 3118992 [TBL] [Abstract][Full Text] [Related]
19. Juvenile chronic myeloid leukaemia and alpha-interferon. Aricò M; Nespoli L; Caselli D; Bonetti F; Porta FA; Burgio GR Eur J Pediatr; 1989 Jan; 148(4):379-80. PubMed ID: 2707286 [No Abstract] [Full Text] [Related]
20. Hemorrhagic fever with renal syndrome: treatment with recombinant alpha interferon. Gui XE; Ho M; Cohen MS; Wang QL; Huang HP; Xie QX J Infect Dis; 1987 May; 155(5):1047-51. PubMed ID: 2881968 [No Abstract] [Full Text] [Related] [Next] [New Search]